Stockhead: Coles Boosts its Exposure to The Calmer Co’s Products by 40% UncategorizedBy Matthew ReedeAugust 2, 2024Leave a comment
Stockhead: The Calmer Co Achieves Record Sales in Q4 & Plans US Expansion UncategorizedBy Matthew ReedeAugust 1, 2024Leave a comment
Stockhead: Kava Player The Calmer Co Eyes Growth After $2.9 Funding UncategorizedBy Matthew ReedeJuly 10, 2024Leave a comment
East Coast Research: Analyst Upgrades Target Price to .017 UncategorizedBy Matthew ReedeJuly 4, 2024Leave a comment
The Australian: Wellness Stocks Offering Calm and Relief UncategorizedBy Matthew ReedeJune 21, 2024Leave a comment
Stockhead: ASX Wellness Stocks Offering Calm and Relief UncategorizedBy Matthew ReedeJune 21, 2024Leave a comment
Sydney Morning Herald: Wellness Company Delivers Nerve Calming Goods UncategorizedBy Matthew ReedeJune 7, 2024Leave a comment
The Market Online: The Calmer Co Sees Shares Rise 83% on News of Record Online Sales for May UncategorizedBy Matthew ReedeJune 5, 2024Leave a comment
Stockhead: The Calmer Co Jumps 100% on Strong Momentum in May UncategorizedBy Matthew ReedeJune 5, 2024Leave a comment
